GB201802354D0 - Treatment of chronic obstructive pulmonary disease - Google Patents

Treatment of chronic obstructive pulmonary disease

Info

Publication number
GB201802354D0
GB201802354D0 GBGB1802354.9A GB201802354A GB201802354D0 GB 201802354 D0 GB201802354 D0 GB 201802354D0 GB 201802354 A GB201802354 A GB 201802354A GB 201802354 D0 GB201802354 D0 GB 201802354D0
Authority
GB
United Kingdom
Prior art keywords
treatment
pulmonary disease
chronic obstructive
obstructive pulmonary
chronic
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
GBGB1802354.9A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Mereo Biopharma 1 Ltd
Original Assignee
Mereo Biopharma 1 Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Mereo Biopharma 1 Ltd filed Critical Mereo Biopharma 1 Ltd
Priority to GBGB1802354.9A priority Critical patent/GB201802354D0/en
Publication of GB201802354D0 publication Critical patent/GB201802354D0/en
Priority to JP2020531621A priority patent/JP7280627B2/en
Priority to AU2018381874A priority patent/AU2018381874A1/en
Priority to US15/733,212 priority patent/US11701341B2/en
Priority to JP2020531614A priority patent/JP7372680B2/en
Priority to ES18819365T priority patent/ES2884789T3/en
Priority to DK18819366.8T priority patent/DK3585383T3/en
Priority to ES18819366T priority patent/ES2882978T3/en
Priority to PL18819366T priority patent/PL3585383T3/en
Priority to PT188193668T priority patent/PT3585383T/en
Priority to KR1020207019714A priority patent/KR20200097310A/en
Priority to CA3085544A priority patent/CA3085544A1/en
Priority to PT188193650T priority patent/PT3585382T/en
Priority to EP21156673.2A priority patent/EP3845228A1/en
Priority to PL18819365T priority patent/PL3585382T3/en
Priority to US15/733,213 priority patent/US11234967B2/en
Priority to AU2018382895A priority patent/AU2018382895B2/en
Priority to DK18819365.0T priority patent/DK3585382T3/en
Priority to HUE18819366A priority patent/HUE054266T2/en
Priority to PCT/GB2018/053590 priority patent/WO2019116021A1/en
Priority to EP18819366.8A priority patent/EP3585383B1/en
Priority to PCT/GB2018/053591 priority patent/WO2019116022A1/en
Priority to EP18819365.0A priority patent/EP3585382B1/en
Priority to KR1020207019715A priority patent/KR20200097311A/en
Priority to CA3085545A priority patent/CA3085545A1/en
Priority to HUE18819365A priority patent/HUE055425T2/en
Ceased legal-status Critical Current

Links

GBGB1802354.9A 2017-12-11 2018-02-13 Treatment of chronic obstructive pulmonary disease Ceased GB201802354D0 (en)

Priority Applications (26)

Application Number Priority Date Filing Date Title
GBGB1802354.9A GB201802354D0 (en) 2018-02-13 2018-02-13 Treatment of chronic obstructive pulmonary disease
HUE18819365A HUE055425T2 (en) 2017-12-11 2018-12-11 Use of 3-[5-amino-4-(3-cyanobenzoyl)-pyrazol-1-yl]-n-cyclopropyl-4-methylbenzamide in the treatment of acute exacerbations of chronic obstructive pulmonary disease
PT188193650T PT3585382T (en) 2017-12-11 2018-12-11 Use of 3-[5-amino-4-(3-cyanobenzoyl)-pyrazol-1-yl]-n-cyclopropyl-4-methylbenzamide in the treatment of acute exacerbations of chronic obstructive pulmonary disease
PL18819365T PL3585382T3 (en) 2017-12-11 2018-12-11 Use of 3-[5-amino-4-(3-cyanobenzoyl)-pyrazol-1-yl]-n-cyclopropyl-4-methylbenzamide in the treatment of acute exacerbations of chronic obstructive pulmonary disease
US15/733,212 US11701341B2 (en) 2017-12-11 2018-12-11 Use of 3-[5-amino-4-(3-cyanobenzoyl)-pyrazol-1-yl]-n-cyclopropyl-4-methylbenzamide in the treatment of acute exacerbations of chronic obstructive pulmonary disease
JP2020531614A JP7372680B2 (en) 2017-12-11 2018-12-11 Use of 3-[5-amino-4-(3-cyanobenzoyl)-pyrazol-1-yl]-N-cyclopropyl-4-methylbenzamide in the prevention or reduction of acute exacerbations of chronic obstructive pulmonary disease.
ES18819365T ES2884789T3 (en) 2017-12-11 2018-12-11 Use of 3- [5-amino-4- (3-cyanobenzoyl) -pyrazol-1-yl] -N-cyclopropyl-4-methylbenzamide in the treatment of acute exacerbations of chronic obstructive pulmonary disease
DK18819366.8T DK3585383T3 (en) 2017-12-11 2018-12-11 USE OF 3- [5-AMINO-4- (3-CYANOBENZOYL) -PYRAZOL-1-YL] -N-CYCLOPROPYL-4-METHYLBENZAMIDE IN THE PREVENTION OF ACUTE EXTENSIONS OF CHRONIC OBSTRUCTIVE
ES18819366T ES2882978T3 (en) 2017-12-11 2018-12-11 Use of 3- [5-amino-4- (3-cyanobenzoyl) -pyrazol-1-yl] -N-cyclopropyl-4-methylbenzamide in the prevention of acute exacerbations of chronic obstructive pulmonary disease
PL18819366T PL3585383T3 (en) 2017-12-11 2018-12-11 Use of 3-[5-amino-4-(3-cyanobenzoyl)-pyrazol-1-yl]-n-cyclopropyl-4-methylbenzamide in the prevention of acute exacerbations of chronic obstructive pulmonary disease
PT188193668T PT3585383T (en) 2017-12-11 2018-12-11 Use of 3-[5-amino-4-(3-cyanobenzoyl)-pyrazol-1-yl]-n-cyclopropyl-4-methylbenzamide in the prevention or reduction of acute exacerbations of chronic obstructive pulmonary disease
KR1020207019714A KR20200097310A (en) 2017-12-11 2018-12-11 Use of 3-[5-amino-4-(3-cyanobenzoyl)-pyrazol-1-yl]-N-cyclopropyl-4-methylbenzamide in the prevention or reduction of acute exacerbation of chronic obstructive pulmonary disease
CA3085544A CA3085544A1 (en) 2017-12-11 2018-12-11 Use of 3-[5-amino-4-(3-cyanobenzoyl)-pyrazol-1-yl]-n-cyclopropyl-4-methylbenzamide in the prevention or reduction of acute exacerbations of chronic obstructive pulmonary disease
JP2020531621A JP7280627B2 (en) 2017-12-11 2018-12-11 Use of 3-[5-amino-4-(3-cyanobenzoyl)-pyrazol-1-yl]-N-cyclopropyl-4-methylbenzamide in the treatment of acute exacerbations of chronic obstructive pulmonary disease
EP21156673.2A EP3845228A1 (en) 2017-12-11 2018-12-11 Use of 3-[5-amino-4-(3-cyanobenzoyl)-pyrazol-1-yl]-n-cyclopropyl-4-methylbenzamide in the prevention or reduction of acute exacerbations of chronic obstructive pulmonary disease
AU2018381874A AU2018381874A1 (en) 2017-12-11 2018-12-11 Use of 3-(5-amino-4-(3-cyanobenzoyl)-pyrazol-1-yl)-N-cyclopropyl-4-methylbenzamide in the prevention or reduction of acute exacerbations of chronic obstructive pulmonary disease
US15/733,213 US11234967B2 (en) 2017-12-11 2018-12-11 Use of 3-[5-amino-4-(3-cyanobenzoyl)-pyrazol-1-yl]-n-cyclopropyl-4-methylbenzamide in the prevention or reduction of acute exacerbations of chronic obstructive pulmonary disease
AU2018382895A AU2018382895B2 (en) 2017-12-11 2018-12-11 Use of 3-(5-amino-4-(3-cyanobenzoyl)-pyrazol-1-yl)-N-cyclopropyl-4-methylbenzamide in the treatment of acute exacerbations of chronic obstructive pulmonary disease
DK18819365.0T DK3585382T3 (en) 2017-12-11 2018-12-11 USE OF 3- [5-AMINO-4- (3-CYANOBENZOYL) -PYRAZOL-1-YL] -N-CYCLOPROPYL-4-METHYLBENZAMIDE IN THE TREATMENT OF ACUTE EXTENSIONS OF CHRONIC OBSTRUCTIVE LUNG
HUE18819366A HUE054266T2 (en) 2017-12-11 2018-12-11 Use of 3-[5-amino-4-(3-cyanobenzoyl)-pyrazol-1-yl]-n-cyclopropyl-4-methylbenzamide in the prevention of acute exacerbations of chronic obstructive pulmonary disease
PCT/GB2018/053590 WO2019116021A1 (en) 2017-12-11 2018-12-11 Use of 3-[5-amino-4-(3-cyanobenzoyl)-pyrazol-1-yl]-n-cyclopropyl-4-methylbenzamide in the treatment of acute exacerbations of chronic obstructive pulmonary disease
EP18819366.8A EP3585383B1 (en) 2017-12-11 2018-12-11 Use of 3-[5-amino-4-(3-cyanobenzoyl)-pyrazol-1-yl]-n-cyclopropyl-4-methylbenzamide in the prevention of acute exacerbations of chronic obstructive pulmonary disease
PCT/GB2018/053591 WO2019116022A1 (en) 2017-12-11 2018-12-11 Use of 3-[5-amino-4-(3-cyanobenzoyl)-pyrazol-1-yl]-n-cyclopropyl-4-methylbenzamide in the prevention or reduction of acute exacerbations of chronic obstructive pulmonary disease
EP18819365.0A EP3585382B1 (en) 2017-12-11 2018-12-11 Use of 3-[5-amino-4-(3-cyanobenzoyl)-pyrazol-1-yl]-n-cyclopropyl-4-methylbenzamide in the treatment of acute exacerbations of chronic obstructive pulmonary disease
KR1020207019715A KR20200097311A (en) 2017-12-11 2018-12-11 Use of 3-[5-amino-4-(3-cyanobenzoyl)-pyrazol-1-yl]-N-cyclopropyl-4-methylbenzamide in the treatment of acute exacerbation of chronic obstructive pulmonary disease
CA3085545A CA3085545A1 (en) 2017-12-11 2018-12-11 Use of 3-[5-amino-4-(3-cyanobenzoyl)-pyrazol-1-yl]-n-cyclopropyl-4-methylbenzamide in the treatment of acute exacerbations of chronic obstructive pulmonary disease

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB1802354.9A GB201802354D0 (en) 2018-02-13 2018-02-13 Treatment of chronic obstructive pulmonary disease

Publications (1)

Publication Number Publication Date
GB201802354D0 true GB201802354D0 (en) 2018-03-28

Family

ID=61731230

Family Applications (1)

Application Number Title Priority Date Filing Date
GBGB1802354.9A Ceased GB201802354D0 (en) 2017-12-11 2018-02-13 Treatment of chronic obstructive pulmonary disease

Country Status (1)

Country Link
GB (1) GB201802354D0 (en)

Similar Documents

Publication Publication Date Title
IL267924B (en) Azolopyrimidine for the treatment of cancer-related disorders
IL273693A (en) Treatment of inflammatory disorders
GB201500314D0 (en) Pharmaceutical formulations for the treatment of pulmonary arterial hypertension
IL279260A (en) Kdm1a inhibitors for the treatment of disease
IL272314A (en) Use of inhaled nitric oxide for the treatment of pulmonary hypertension associated with lung disease
EP3897641C0 (en) Treatment of movement disorders
ZA202105111B (en) Pharmaceutical composition for the treatment of pulmonary arterial hypertension
IL291372A (en) Treatment of chronic granulomatous disease
RS64666B1 (en) Dulaglutide for the treatment of chronic kidney disease
IL253688A (en) New compositions and methods of treating and/or preventing chronic obstructive pulmonary disease
GB201515244D0 (en) Treatment of inflammatory disease or condition
GB201802354D0 (en) Treatment of chronic obstructive pulmonary disease
GB201802353D0 (en) Treatment of chronic obstructive pulmonary disease
EP3383415A4 (en) Use of mitochondrial iron chelators for treatment of chronic obstructive pulmonary disease
PT3585382T (en) Use of 3-[5-amino-4-(3-cyanobenzoyl)-pyrazol-1-yl]-n-cyclopropyl-4-methylbenzamide in the treatment of acute exacerbations of chronic obstructive pulmonary disease
SG11202006601VA (en) Methods of treating chronic inflammatory diseases
GB201604359D0 (en) Treatment of tissue disorders
GB201811911D0 (en) Treatment of disease
GB201811912D0 (en) Treatment of disease
GB201810974D0 (en) Treatment of disease
GB201809835D0 (en) Treatment of gastrointestinal disease
EP4065167A4 (en) Cela-1 inhibition for treatment of lung disease
GB201804603D0 (en) Treatment of antiretroviral disease
GB201915768D0 (en) Treatment of lung conditions
IL272422A (en) Methods for the treatment of leptomeningeal disease

Legal Events

Date Code Title Description
AT Applications terminated before publication under section 16(1)